Inactive Instrument

Insiders Hansa Biopharma AB Nasdaq Stockholm

Equities

SE0002148817

Real-time Estimate Cboe Europe Other stock markets 10:13:30 2024-04-29 am EDT			5-day change	1st Jan Change
28.63 ^SEK	-82.47%		-5.78%	-38.73%

Apr. 18	Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024
Apr. 18	Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hansa Biopharma Hires New CFO	Feb. 22	MT
Hansa Biopharma Nomination Committee Formed	Dec. 13	CI
Sweden's Hansa Biopharma CFO to Depart in February 2024	Nov. 27	MT
Hahansa Biopharma AB Announces Resignation of Donato Spota as Chief Financial Officer, Effective 28 February 2024	Nov. 27	CI
Sweden’s Hansa Biopharma Appoints New Chief Scientific Officer	23-09-01	MT
Hitto Kaufmann Appointed Chief Scientific Officer of Hansa Biopharma, Effective 1 December 2023	23-09-01	CI
Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma	23-03-06	AQ
Hansa Biopharma Names Former Pfizer Exec as Chief Commercial Officer	23-03-03	MT
Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma	23-03-03	AQ
Hansa Biopharma AB Appoints Matthew Shaulis as Chief Commercial Officer and US President of Hansa Biopharma	23-03-03	CI
Hansa Biopharma Chief Scientific Officer to Step Down in 2024	23-01-30	MT
Hansa Biopharma Announces Planned Departure of Chief Scientific Officer Christian Kjellman	23-01-30	CI
Correction Hansa Biopharma Nomination Committee formed	22-12-29	AQ
Correction: Hansa Biopharma Nomination Committee formed	22-12-28	AQ
Hansa Biopharma Nomination Committee formed - December 23, 2022	22-12-23	AQ
Hansa Biopharma Nomination Committee formed	22-12-23	AQ
Hansa Biopharma AB Announces Formation of Nomination Committee	22-12-23	CI
Hansa Biopharma AB Appoints Peter Nicklin as A New Member of the Board of Director	22-06-30	CI
Hansa Biopharma AB's Current Chair Ulf Wiinberg Has Chosen to Not Stand for Re-Election	22-05-30	CI
Hansa Biopharma AB Announces Ulf Wiinberg Not to Stand for Re-Election as Director	22-05-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Hansa Biopharma AB Nasdaq Stockholm

Equities

SE0002148817

Insiders

Filters